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Introduction 
Intra- and postoperative bleeding is one of the 
more common surgical complications. Its occurrence 
depends mostly on the type and the extent of the pro-
cedure as well as coagulation profile of the patient. 
In fact, any hematological disorder related to coag-
ulopathy is by definition associated with increased 
risk of perioperative bleeding. Immune thrombocy-
topenia (ITP), also known as idiopathic or immune 
thrombocytopenic purpura, is a  relatively common 
hematologic disease characterized by immune-me-
diated destruction of platelets, mostly in the spleen, 
leading to a low platelet count (PLT) and bleeding [1]. 
Among treatment modalities splenectomy is con-
sidered a main second-line treatment in refractory 
cases that do not respond to conservative manage-
ment. In 1991, the very first laparoscopic splenecto-
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A b s t r a c t
Introduction: Laparoscopic splenectomy (LS) is the gold standard in treating immune thrombocytopenia (ITP). However, 
there are still some problems in decision-making when considering LS in patients with a very low platelet count (PLT).
Aim: To evaluate safety outcomes of LS in patients with severe ITP and very low PLT in comparison to those with 
higher PLT.
Material and methods: We retrospectively analyzed consecutive patients who underwent LS in a single institution 
between April 1998 and December 2017. Perioperative care was based on an algorithm developed at our department 
which takes into consideration the patient’s PLT level. Patients were divided into 2 groups depending on the PLT level 
(cut-off point 50,000/mm3).
Results: The mean operative time in the low PLT group and high PLT group was 90 ±42.1 min and 95 ±45 min, re-
spectively (p = 0.59). Intraoperative blood loss was 144 ±226.1 ml in the low PLT group and 83 ±161.24 ml in the 
high PLT group (p = 0.23). Complications occurred in 5 (9.09%) patients in the low PLT group and 16 (11.51%) in the 
high PLT group (p = 0.67). There were no conversions in the group with lower PLT, while 2 patients in the group with 
higher PLT had to be converted to open surgery (p = 0.38). Patients with low PLT preoperatively more often required 
perioperative platelet transfusions (13 vs. 1, p < 0.001).
Conclusions: Laparoscopic splenectomy is safe and feasible treatment in patients with ITP regardless of the PLT level. 
Still, patients with critical ITP and marginally low PLT require special awareness.
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my (LS) was conducted by Delaitre and Maignien [2]. 
Since then LS has become the gold standard for pa-
tients suffering from ITP and has gradually replaced 
traditional open splenectomy (OS) [3]. Laparoscopic 
splenectomy has many benefits such as lower rates 
of morbidity and mortality, reduced surgical trau-
ma and blood loss, lower postoperative pain, better 
cosmetic appearance and shorter hospital stay [4]. 
Uncorrected coagulopathy is considered an absolute 
contraindication to surgical procedures in general 
and is particularly strongly emphasized in the case 
of laparoscopy [5, 6]. There are potential problems 
in decision-making when considering LS in severe 
cases of ITP with extreme low PLT. It is commonly ac-
cepted that the safe PLT count to perform surgery is 
50,000/mm3, but in patients with ITP it is not always 
possible to achieve [4]. Therefore, in this study we 
aimed to evaluate the safety of LS in patients with 
severe thrombocytopenia. 
Aim
The aim of the study was to evaluate safety out-
comes of laparoscopic splenectomy in patients with 
severe ITP and very low PLT in comparison to those 
with higher PLT.
Material and methods
Consecutive patients undergoing laparoscopic 
splenectomy for ITP in a university tertiary referral 
center between April 1998 and December 2017 were 
included in the study. Before surgery, all patients un-
derwent preoperative assessment and were treated 
conservatively by a consultant hematologist in order 
to control the disease and increase platelet levels. 
In the case of treatment failure or complications re-
lated to used medications, patients underwent elec-
tive laparoscopic splenectomy despite low PLT. De-
cision-making about whether to perform an LS was 
assessed using our internal algorithm. Patients were 
preoperatively managed depending on the PLT level 
(Figure 1): 
1. Patients with PLT ≥ 50,000/mm3 were selected 
for laparoscopic surgery without any additional 
preoperative means.
2. Patients with PLT < 50,000/mm3 were reevalu-
ated by hematologists and an attempt to raise 
platelets to the level ≥ 50,000/mm3 was under-
taken. If successful, patients were treated by LS. 
3. Patients in whom the hematologist were able to 
achieve only a partial response and whose pre-
operative PLT were between 20,000/mm3 and 
50,000/mm3 were scheduled for LS after ensuring 
that the blood bank could deliver platelet trans-
fusions immediately whenever needed. Most of 
them however did not require transfusions. 
4. Patients with preoperative PLT < 20,000/mm3 
despite intensive preoperative conditioning were 
operated on and platelet transfusions were ad-
ministered intraoperatively in order to elevate 
PLT level. 
The operative method of choice in our depart-
ment is a  laparoscopic 4-port splenectomy, which 
was performed as described elsewhere [7]. In some 
patients single incision splenectomy was performed 
[8]. None of the patients with ITP was initially oper-
ated on with an open approach. In all cases routine 
hematological treatment was implemented before 
surgical intervention, and the indications for splenec-
tomy included failure of conservative treatment or 
side-effects of drugs used that did not allow further 
therapy. Preoperatively, platelet level was routinely 
measured within 8 h prior to surgery. For the purpose 
of statistical analyses patients with preoperative PLT 
Figure 1. Decision-making algorithm in patients with ITP who underwent laparoscopic splenectomy
Patient with ITP submitted to laparoscopic splenectomy
Laparoscopic splenectomy  
without PLT transfusion
Laparoscopic splenectomy with 
postoperative PLT transfusion in cases 
who do not respond to splenectomy
Laparoscopic splenectomy with 
intraoperative PLT transfusion
PLT ≥ 50,000/mm3 PLT < 50,000/mm3
Refer to hematologist to intensify treatment
PLT ≥ 50,000/mm3 PLT 20,000–50,000/mm3 PLT < 20,000/mm3
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< 50,000/mm3 (low PLT group) were compared with 
those with PLT ≥ 50,000/mm3 (high PLT group).
The measured outcomes were the operative time, 
intraoperative blood loss, need for blood transfu-
sions, conversion rate and morbidity. Operative time 
was measured from skin incision to closure. The intra-
operative blood loss was measured from the amount 
of blood aspirated in the suction machine. The study 
was conducted according to STROBE guidelines [9]. 
All procedures followed the ethical standards of the 
responsible committee on human experimentation 
(institutional and national) and the sixth revision 
(Fortaleza) of the 1975 Declaration of Helsinki. The 
study was approved by an independent ethics com-
mittee of the Jagiellonian University, Krakow, Poland 
(approval number 1072/6120/160/2017). Informed 
consent for the surgical treatment was obtained 
from all patients before the procedure. 
Patients
Out of 543 patients undergoing laparoscopic 
splenectomy in our department in the study period, 
194 were operated on for ITP. Group 1 consisted 
of 9 patients with PLT < 20,000/mm3. group 2 con-
sisted of 46 patients with PLT ≥ 20,000/mm3 and 
PLT < 50,000/mm3. Group 3 comprised 114 patients 
with initial PLT < 50,000/mm3 that was elevated to 
at least 50,000/mm3 preoperatively, and group 4 
included 25 patients with PLT ≥ 50,000/mm3. Pa-
tients’ demographic characteristics are presented 
in Table I. For the purpose of statistical analyses 
patients in groups 1 and 2 were combined as the 
low PLT group and analyzed together with groups 
3 and 4 (high PLT group). There were no significant 
differences in demographics between analyzed 
groups (Table I).
Statistical analysis
Statistical analysis was performed using StatSoft 
Statistica version 13.0 software. Normal distribution 
of continuous variables was tested with the c2 test. 
Variables with non-normal distribution were com-
pared using the Mann-Whitney U  test. Categorical 
variables were compared with the c2 test. Results 
Table I. Demographic data of patients
Parameter Group 1  
(PLT < 20,000/mm3)
Group 2  
(PLT ≥ 20,000/mm3
and PLT < 50,000/mm3)
Group 3  
(PLT < 50,000/mm3 
elevated  
to ≥ 50,000/mm3 
before surgery)
Group 4  
(PLT ≥ 50,000/mm3)
P-value
Low PLT group High PLT group
Number of 
patients
9 46 114 25
55 139 –
Male/female 5/4 23/23 41/73 5/20
28/27 46/93 0.21
Age [years] 43.75 ±16.44 35.96 ±15.73 36.82 ±16.23 39.45 ±16.77
40.29 ±17.35 39.98 ±16.5 0.91
PLT 7.5 ±7.93 40.82 ±17.53 130 ±63.16 108.4 ±57.32
32.1 ±13.64 118.1 ±59.8 –
Preoperative 
need for  
glucocorticoids*
9 41 110 22
50 132 0.29
Preoperative  
need for  
immunoglobulins*
1 7 18 1
8 19 0.87
Preoperative 
need for PLT 
transfusions*
5 8 1 0
13 1 < 0.001
*Within 7 days prior to surgery.
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were considered statistically significant when the 
p-value was < 0.05. 
Results
Patients with low PLT preoperatively more often 
required perioperative platelet transfusions (13 vs. 1, 
p < 0.001). The mean operative time in the low PLT 
group and high PLT group was 90 ±42.1 min and 
95 ±45 min, respectively. There were no statistical-
ly significant differences in this parameter between 
groups (p = 0.59, Figure 2). 
Intraoperative blood loss was 144 ±226.1 ml in 
the low PLT group and 83 ±161.24 ml in the high PLT 
group – this difference was not statistically signifi-
cant (p = 0.23, Figure 3).
Complications occurred in 5 (9.09%) patients in 
the low PLT group and 16 (11.51%) in the high PLT 
group (p = 0.67). Characteristics of the complica-
tions are presented in Table II. There were no con-
versions in the group with lower PLT, while 2 patients 
in the group with higher PLT had to be converted 
to open surgery (p = 0.38). The reasons for conver-
Figure 3. Intraoperative blood loss in low PLT 
group and high PLT group
Figure 2. Comparison of the operative time in 
low PLT group and high PLT group
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Table II. Total complications in both groups according to Clavien-Dindo classification
Clavien-Dindo 
grade
Complication Low PLT group (n = 55) High PLT group (n = 139)
I Seroma – fluid collection 0 3 (2.16%)
II Pneumonia 1 (1.81%) 5 (3.6%)
III a Hematoma requiring subcutaneous drainage 1 (1.81%) 0
III b Abscess – required reoperation 1 (1.81%) 2 (1.44%)
Acute pancreatitis – required reoperation 1 (1.81%) 0
Bleeding – required reoperation 1 (1.81%) 3 (2.16%)
Stomach perforation – required reoperation 0 1 (0.72%)
IV b Abscess – required reoperation 0 1 (0.72%)
V Pulmonary embolism 0 1 (0.72%)
Total 5 (9.09%) 16 (11.51%)
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sion were uncontrolled bleeding in both cases: once 
during splenic hilum dissection and once during mo-
bilization of the spleen. A summary of perioperative 
results is presented in Table III. 
Discussion
We have confirmed that LS in patients with se-
vere ITP and very low PLT is safe and feasible. It is 
not associated with a  different course of surgical 
procedure or worse postoperative outcomes. In our 
opinion, the safety of the procedure in patients with 
end-stage thrombocytopenia might be affected by 
the strategy of perioperative management devel-
oped in our department. It is an important finding 
since ITP is one of the most common hematologic 
disorders affecting children and adults with the in-
creasing destruction of platelets caused by the anti-
platelet antibodies. Moreover, it is currently the most 
common indication for non-traumatic splenectomy. 
The percentage of patients with ITP who will even-
tually need splenectomy is reported to be, according 
to large series, as high as 20–45% [10–13]. 
According to recent a meta-analysis of more than 
7,200 patients, LS for non-traumatic diseases of the 
spleen is superior to OS in terms of reduced blood 
loss and requirement for blood transfusion, lower 
morbidity and mortality rates and shorter length 
of hospital stay [14]. For these reasons, LS is now 
considered the gold standard for patients with ITP. 
Although there is a small percentage (7–22%) of pa-
tients who do not respond to the treatment, it is still 
the best option in patients not eligible for conserva-
tive management [15]. 
Preoperative clinical symptoms of thrombocyto-
penia cause a great risk to patients and are some-
times regarded as a  contraindication to surgery 
depriving patients of an effective method of treat-
ment. Since the spleen in ITP is usually not enlarged, 
the greatest concern is low PLT that might lead to 
perioperative hemorrhage, difficulties with hemo-
stasis requiring conversion and subsequent blood 
transfusions. On one hand it has been proven that 
LS significantly reduces the blood loss and need for 
platelet transfusion compared to open surgery [16]. 
On the other hand, coagulopathy is the absolute 
contraindication to laparoscopy in most guidelines 
and it should be corrected before surgery, which for 
obvious reasons is not possible in the majority of ITP 
patients [17]. Therefore, according to some authors, 
LS in low PLT should be contraindicated, whereas 
PLT higher than 50,000/mm3 is considered sufficient 
for effective hemostasis [18–20].
In our study, almost 30% of patients undergoing 
LS had PLT below 50,000/mm3 despite the most op-
timal preoperative management and adjustment of 
thrombocytopenia. Importantly, we have shown that 
low PLT is not associated with higher complication 
rates (complications occurred in 5 (9.09%) patients 
in the low PLT group and in 16 (11.51%) in the high 
PLT group). It was achieved with no difference in op-
erative technique. For instance, despite very low PLT 
we still do not use drains, which according to previ-
ous observations do not bring any benefits and in 
some clinical situations may increase complication 
rates [21]. This confirms that LS is feasible and safe 
also in this, theoretically more dangerous, clinical sit-
uation. We did not find any statistically significant 
differences in either complication rates or their se-
verity between groups. Patients with very low PLT 
did not present an increased rate of perioperative 
bleeding, which might be related to PLT level. In 
our study 1 patient from the low PLT group needed 
relaparoscopy because of bleeding, and 3 patients 
from the high PLT group. Two of them required con-
version. These results are in line with other reports 
where complication rates were around 10%, with 
lower morbidity in high-volume centers as noted by 
Montalvo et al. [22]. Although in our study we did 
not find any relationship between PLT and LS out-
Table III. Summary of findings
Parameter Low PLT group High PLT group P-value
Operative time [min] 90 ±42.1 95 ±45 0.59
Intraoperative blood loss [ml] 144 ±226.1 83 ±161.24 0.23
Complication rate 5 (9.09%) 16 (11.51%) 0.67
Perioperative platelet transfusions 13 (23.6%) 1 (0.7%) < 0.001
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comes, there are previously published reports show-
ing that severe thrombocytopenia might be a  risk 
factor for increased morbidity. For instance, Keidar 
et al. showed that patients with severe thrombocy-
topenia had significantly more packed red cell trans-
fusions and a much longer stay [23]. Both univariate 
and multivariate analysis of predictive factors by 
Duperier et al. confirmed that higher preoperative 
platelet count is associated with a  successful re-
sponse to LS [24].
We did not find any difference between low PLT 
level and greater difficulty of LS resulting in differ-
ences in operative time, increased blood loss or 
conversion rate. Having said that, the results may 
be biased because we did not take into account 
surgeons’ experience. It is very likely that the most 
difficult cases were performed by more experienced 
surgeons in laparoscopic surgery of the spleen. On 
the other hand, the operative time in our study was 
lower than reported elsewhere. Chen et al. reported 
that from a  group of 81 patients 9% had massive 
bleeding, 4 of them requiring conversion to open 
surgery [1]. Machado et al. found in their study that 
mean blood loss was 70 (range: 50–460) ml and op-
erative time was 126 (range: 110–240) min [25]. In 
a systematic review Moris et al. found that LS can 
be performed with minimal blood loss (30–60 ml), 
operative time was reported as 75–165 min, and the 
conversion rate to OS was in the range 0–4% [26].
In order to establish optimal perioperative man-
agement, we developed a  simple, easy to follow 
algorithm (Figure 1) for all surgeons dealing with 
patients with ITP. Every patient has to be referred 
by a  consultant hematologist who confirms that 
LS is the optimal treatment of ITP at this stage. In 
all cases with PLT ≥ 50,000 mm3 no additional pre-
operative means of treatment are needed and pa-
tients can be operated on safely. In patients whose 
PLT assessed just before surgery is < 50,000 mm3, 
treatment modification is needed. They are referred 
back to the hematologist for further assessment and 
potential treatment modification. If hematologic in-
tervention is successful (PLT ≥ 50,000 mm3) they can 
undergo LS. Patients with PLT between 20,000 and 
50,000/mm3 despite intensive management and 
use of all therapeutic options may require platelet 
transfusions. Therefore 2 packs of platelets should 
be waiting in the blood bank to be ready for immedi-
ate transfusion in patients who do not respond to LS 
and sustain a low PLT count. Finally, the majority of 
patients with preoperative PLT < 20,000 mm2 will re-
quire intraoperative PLT transfusions. Therefore, we 
suggest considering starting transfusion of the first 
PLT unit at the beginning of the procedure and the 
next one once the splenic artery has been clipped. 
Generally the operative strategy is slightly different 
in those patients. The surgeon should identify, dis-
sect and clip the splenic artery as early in the course 
of the operation as possible. This maneuver termi-
nates PLT destruction in the spleen in most cases 
and allows for further dissection. With this strategy 
we were able to operate even on patients whose PLT 
level just before surgery was 0. In our study, periop-
erative platelet transfusions were necessary only in 
13 cases (in 6 cases during surgery and in the re-
maining 7 patients due to failure in PLT elevation 
postoperatively) in the low PLT group and 1 case in 
the group with high PLT (the patient did not respond 
to splenectomy). There are reports suggesting that 
continuous PLT transfusion may be successful in cas-
es of serious uncontrolled bleeding with PLT below 
the measurable limit [27]. 
The limitations of the study are typical for a sin-
gle retrospective analysis. In addition, we did not an-
alyze other parameters that might influence the out-
comes such as body mass index, previous abdominal 
surgery or the presence of an accessory spleen. Al-
though they might have influenced the outcomes to 
some extent, none of them were identified as a rea-
son for conversion or massive intraoperative bleed-
ing. Moreover, due to the relatively small number of 
patients with very severe ITP (PLT < 20,000 mm3) we 
were not able to analyze them separately in order to 
achieve sufficient statistical power.
Conclusions
Our study confirms that LS is a safe and feasible 
surgical approach in patients with ITP regardless of 
the preoperative PLT. The procedure is not associ-
ated with a  longer operative time, increased blood 
loss or conversion rate. Patients with low PLT are not 
at risk of increased morbidity. For these reasons, LS 
should be considered the gold standard in the sur-
gical treatment of ITP. However, special precautions 
must be taken in the group of patients with severe 
ITP and extremely low PLT. 
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